Search Results for 'Sofosbuvir-Rbv'

Sofosbuvir-Rbv published presentations and documents on DocSlides.

Daclatasvir  + Sofosbuvir + RBV in GT3
Daclatasvir + Sofosbuvir + RBV in GT3
by sophia2
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation
Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation
by ahmir653
SOLAR-2. Source: . Manns. M, et al. Lancet Infect...
Ledipasvir-Sofosbuvir   RBV in HCV GT 1,4 and Advanced Liver Disease
Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease
by alida-meadow
SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
by debby-jeon
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
Ledipasvir-Sofosbuvir (
Ledipasvir-Sofosbuvir (
by lindy-dunigan
Harvoni. ). Prepared by: . David H. Spach, MD and...
Sofosbuvir in
Sofosbuvir in
by giovanna-bartolotta
Genotype . 2. . or 3 . FUSION. Trial. Phase . ...
Sofosbuvir
Sofosbuvir
by conchita-marotz
ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Sofosbuvir  + Ribavirin in HCV Recurrence
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
Sofosbuvir  + Ribavirin to Prevent Post-Transplant HCV Recurrence
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
Ledipasvir-Sofosbuvir ( Harvoni
Ledipasvir-Sofosbuvir ( Harvoni
by sherrill-nordquist
). Slide deck prepared . by: . David H. Spach, MD...
Sofosbuvir-Velpatasvir  in HCV Genotype 1, 2, 4, 5, or 6
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Sofosbuvir-Velpatasvir  in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by trish-goza
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
Sofosbuvir in Genotypes 2 or 3
Sofosbuvir in Genotypes 2 or 3
by giovanna-bartolotta
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
Ledipasvir-Sofosbuvir +/- 3
Ledipasvir-Sofosbuvir +/- 3
by alexa-scheidler
rd. DAA in HCV Genotype 1 . NIAID SYNERGY: Genot...
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
by pamella-moone
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
Sofosbuvir in HCV-
Sofosbuvir in HCV-
by mitsue-stanley
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
Sofosbuvir + Ribavirin in HCV Genotype 1
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Ledipasvir-Sofosbuvir in GT1 or GT4 and HIV Coinfection
Ledipasvir-Sofosbuvir in GT1 or GT4 and HIV Coinfection
by pasty-toler
ION-4. Phase . 3. Treatment. Naïve and Treatmen...
Ledipasvir-Sofosbuvir in GT-1
Ledipasvir-Sofosbuvir in GT-1
by faustina-dinatale
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
Buy sofosbuvir 400mg Tablets Online
Buy sofosbuvir 400mg Tablets Online
by richardbroody
Buy Sofosbuvir 400mg tablets online from Reliable ...
Ledipasvir 90mg Sofosbuvir 400mg Tablets
Ledipasvir 90mg Sofosbuvir 400mg Tablets
by dennissdugans
Buy Ledifos Tablets Online from Complete Online Ph...
Sofosbuvir, Ribavirin, GS
Sofosbuvir, Ribavirin, GS
by min-jolicoeur
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by webraph
Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Updated Guidelines for Managing HIV/HCV Co-Infection
Updated Guidelines for Managing HIV/HCV Co-Infection
by karlyn-bohler
John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
HIV and HCV Update for the Pharmacist – June 2014
HIV and HCV Update for the Pharmacist – June 2014
by marina-yarberry
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...
C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3
C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3
by UnicornLove
C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...
PEG alfa-2a    RBV  versus
PEG alfa-2a RBV versus
by alexa-scheidler
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
SOF + RBV
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
SOF + EBR + GZR + RBV
SOF + EBR + GZR + RBV
by test
N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...
MK3 MK3  + RBV
MK3 MK3 + RBV
by min-jolicoeur
Randomisation. Open-label. W8. * Liver biopsy or ...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...